Rob Pieters

20PUBLICATIONS
152CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene expression (incl. microarray and other genome-wide approaches)Cancer geneticsHaematological tumoursImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Jan 08, 2026
Sustained Benefit of Blinatumomab in Infants With <i>KMT2A</i>-Rearranged ALL: Long-Term Outcomes, Toxicity, and Pharmacokinetics.

Miguel Vieira Martins, Paola de Lorenzo, Rishi S Kotecha

|Oct 08, 2025
The genomic landscape of relapsed infant and childhood KMT2A-rearranged acute leukemia.

Louise Ahlgren, Mattias Pilheden, Helena Sturesson

|Feb 28, 2025
Challenging Conventional Diagnostic Methods by Comprehensive Molecular Diagnostics: A Nationwide Prospective Comparison in Children With ALL.

Judith M Boer, Marco J Koudijs, Lennart A Kester

|Sep 10, 2024
Are measurable residual disease results after consolidation therapy useful in children with acute lymphoblastic leukemia?

Janine Stutterheim, Rachella van der Waarden, Hester A de Groot-Kruseman

|Aug 28, 2024
Increased risk of subsequent neoplasm after hematopoietic stem cell transplantation in 5-year survivors of childhood acute lymphoblastic leukemia.

Aimée S R Westerveld, Pien Roesthuis, Helena J H van der Pal

|Jul 04, 2024
Integration of genetics and MRD to define low risk patients with B-cell precursor acute lymphoblastic leukaemia with intermediate MRD levels at the end of induction.

Anthony V Moorman, Amir Enshaei, Daniel Murdy

Pageof 4

Frequent Collaborators

5 joint publications

Andishe Attarbaschi

5 joint publications

Valérie de Haas

5 joint publications

Kjeld Schmiegelow

4 joint publications

Martin Schrappe